ClinicalTrials.gov
ClinicalTrials.gov Menu

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00084656
Recruitment Status : Completed
First Posted : June 11, 2004
Last Update Posted : April 26, 2010
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Study Completion Date : No date given